Get the Stockscreener App
6.63
0.45%
-0.03
Lifestance Health Group Inc stock is traded at $6.63, with a volume of 1.25M.
It is down -0.45% in the last 24 hours and down -14.89% over the past month.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
See More
Previous Close:
$6.66
Open:
$6.63
24h Volume:
1.25M
Relative Volume:
0.84
Market Cap:
$2.55B
Revenue:
$1.21B
Net Income/Loss:
$-95.29M
P/E Ratio:
-25.50
EPS:
-0.26
Net Cash Flow:
$35.06M
1W Performance:
-2.07%
1M Performance:
-14.89%
6M Performance:
-3.77%
1Y Performance:
+6.94%
1-Day Range:
$6.56
$6.795
1-Week Range:
$6.52
$6.81
52-Week Range:
$4.64
$8.61
Lifestance Health Group Inc Stock (LFST) Company Profile
Name
Lifestance Health Group Inc
Sector
Industry
Phone
602-767-2100
Address
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Compare LFST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFST
Lifestance Health Group Inc
|
6.63 | 2.55B | 1.21B | -95.29M | 35.06M | -0.26 |
|
HCA
Hca Healthcare Inc
|
345.73 | 85.12B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.74 | 14.52B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
151.91 | 13.32B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
133.40 | 13.03B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
187.81 | 12.21B | 15.42B | 1.03B | 956.84M | 15.02 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-24 | Upgrade | Goldman | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Underweight |
| May-15-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-06-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-07-22 | Resumed | Jefferies | Buy |
| Mar-17-22 | Downgrade | UBS | Buy → Neutral |
| Nov-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-06-21 | Initiated | Goldman | Neutral |
| Jul-06-21 | Initiated | JP Morgan | Overweight |
| Jul-06-21 | Initiated | Jefferies | Buy |
| Jul-06-21 | Initiated | Morgan Stanley | Overweight |
| Jul-06-21 | Initiated | William Blair | Outperform |
View All
Lifestance Health Group Inc Stock (LFST) Latest News
April 2025's Leading Growth Companies With High Insider Ownership - simplywall.st
When Will LifeStance Health Group, Inc. (NASDAQ:LFST) Become Profitable? - Yahoo Finance
LifeStance Health Group, Inc. (LFST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
LifeStance Health Group (NASDAQ:LFST) Is Carrying A Fair Bit Of Debt - simplywall.st
LifeStance Health EVP Lisa K. Miller sells $130,030 in stock By Investing.com - Investing.com Australia
Top Executive Sells Thousands of Lifestance Health Group Shares - TipRanks
LifeStance Health EVP Lisa K. Miller sells $130,030 in stock - Investing.com India
How to Take Advantage of moves in (LFST) - news.stocktradersdaily.com
A significant driver of top-line growth: LifeStance Health Group Inc (LFST) - SETE News
LifeStance Health Group’s chief digital officer sells $264,293 in stock By Investing.com - Investing.com Australia
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH) - The Globe and Mail
LifeStance Health Group’s chief digital officer sells $264,293 in stock - Investing.com India
LifeStance Health Group Enters Oversold Territory (LFST) - Nasdaq
(LFST) Investment Analysis and Advice - Stock Traders Daily
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies LifeStance Health Group, Inc. (LFST) Investors of Class Action and to Actively Participate - ACCESS Newswire
LifeStance Health’s Earnings Call Highlights Strong Growth - TipRanks
March 2025 Growth Companies With Strong Insider Confidence - Simply Wall St
UBS Adjusts Price Target on Lifestance Health Group to $8.50 From $7.50, Maintains Neutral Rating - Marketscreener.com
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2024 Earnings Call Transcript - MSN
LifeStance Health Group’s (LFST) Outperform Rating Reiterated at William Blair - Defense World
Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Target Price at $8.70 - Defense World
LifeStance Health Group (NASDAQ:LFST) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Posts Quarterly Earnings Results - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Is Now An Opportune Moment To Examine LifeStance Health Group, Inc. (NASDAQ:LFST)? - Yahoo Finance UK
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Purchased by Blue Trust Inc. - Defense World
Critical Review: LifeStance Health Group (NASDAQ:LFST) and Vsee Health (NASDAQ:VSEE) - Defense World
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of LifeStance Health Group, Inc. (LFST) Investigation - ACCESS Newswire
LifeStance Health Group Reports Strong 2024 Growth - TipRanks
Earnings call transcript: LifeStance Health Q4 2024 beats EPS expectations By Investing.com - Investing.com South Africa
Dave Bourdon to join LifeStance Health as new CEO - MSN
LifeStance Health Group, Inc. SEC 10-K Report - TradingView
Lifestance Health Names Dave Bourdon as CEO, Ryan McGroarty as CFO -February 27, 2025 at 11:21 am EST - Marketscreener.com
Earnings call transcript: LifeStance Health Q4 2024 beats EPS expectations - Investing.com
Lifestance Health Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeStance Health Group, Inc. Announces Chief Financial Officer Changes -February 27, 2025 at 06:02 am EST - Marketscreener.com
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman - The Malaysian Reserve
Lifestance Health Group earnings beat by $0.03, revenue topped estimates - Investing.com UK
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lifestance Health Group's Q4 Loss Narrows, Revenue Rises; Provides 2025 Revenue Guidance - Marketscreener.com
Lifestance Health Group Announces Leadership Changes for 2025 - TipRanks
LifeStance Health Names Bourdon CEO; Burdick Becomes Executive Chairman - MarketWatch
LifeStance Health Group (NASDAQ:LFST) Beats Expectations in Strong Q4, Stock Soars - Yahoo Finance
LifeStance Reports Fourth Quarter and Full Year 2024 Results - The Manila Times
How LifeStance's Mental Health Bet Paid Off: 19% Revenue Surge and Doubled EBITDA - StockTitan
LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect By Stock Story - Investing.com Canada
LifeStance Health Group Insiders Sell US$6.3m Of Stock, Possibly Signalling Caution - Simply Wall St
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages LifeStance Health Group (LFST) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Pending - ACCESS Newswire
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
Lifestance Health Group Inc Stock (LFST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):